CV Sciences (CVSI) Non-Current Debt (2013 - 2025)

CV Sciences (CVSI) reported Non-Current Debt of $387000.0 for Q4 2025, down 23.21% sequentially from $504000.0 in Q3 2025.

CV Sciences (CVSI) Non-Current Debt (2013 - 2025) Analysis & Trends

CV Sciences (CVSI) has 8 years of Non-Current Debt data on file, last reported at $387000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt changed N/A year-over-year to $387000.0; the trailing twelve-month figure through Dec 2025 stood at $387000.0 (changed N/A YoY), and the FY2025 full-year result was $387000.0, changed N/A from the prior year.
  • Non-Current Debt fell to $387000.0 in Q4 2025, from $504000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q1 2022 to a low of $208000.0 in Q2 2025.
  • A 3-year average of $878444.4 and a median of $504000.0 in 2025 frame the typical range for Non-Current Debt.
  • Peak annual rise in Non-Current Debt reached 375.21% in 2022, while the deepest fall reached 123.74% in 2022.
  • Tracing CVSI's Non-Current Debt over 3 years: stood at $771000.0 in 2021, then soared by 123.74% to $1.7 million in 2022, then tumbled by 77.57% to $387000.0 in 2025.
  • Business Quant data shows CVSI's Non-Current Debt at $387000.0 in Q4 2025, $504000.0 in Q3 2025, and $208000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 387,000.00
Sep 30, 2025 504,000.00
Jun 30, 2025 208,000.00
Mar 31, 2025 498,000.00
Dec 31, 2022 1.73 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 1.73 Mn
Dec 31, 2021 771,000.00
Mar 31, 2021 363,000.00
Sep 30, 2020 2.54 Mn
Jun 30, 2020 2.91 Mn
Mar 31, 2018 850,000.00
Dec 31, 2017 1.58 Mn
Dec 31, 2016 679,174.00
Sep 30, 2016 639,753.00
Jun 30, 2016 600,332.00
Mar 31, 2016 560,911.00
Dec 31, 2013 5.50 Mn
Sep 30, 2013 4.21 Mn
Jun 30, 2013 3.28 Mn